-
(Research): 1 year full-time; 2 years part-time; IPhD: 5 years full-time; Apply now Overview Overview Our PhD programmes offer training in all aspects of molecular pharmacology and our large internationally
-
of Cardiovascular and Metabolic Health (e.g. cardiology, renal medicine, clinical pharmacology, chemical pathology, diabetes and endocrinology). 14. The Fellow will be expected to submit grant application(s) as
-
analyses carried out by the School of Cancer Sciences. This covers all GCLP aspects of the Translational Pharmacology Laboratory, based at the WWCRC, the GTRF based at the Queen Elizabeth University Hospital
-
the clinical potential of these compounds and define the best strategies for designing their clinical implementation. The candidate will develop skills in cell culturing, with particular reference to 3D models
-
choices: Biomedical Sciences [MSc] , Cardiovascular Sciences [MSc(MedSci)] , Clinical Pharmacology [MSc(MedSci)] , Medical Genetics & Genomics [MSc(MedSci)] , Precision Medicine (with specialisms) [MSc
-
Our School of Cancer Sciences is a broad-based, research intensive institution with a global reach. We span fundamental cancer biology, translational and clinical cancer research. And focus
-
for disorders known to compromise ones decision making faculties to be used in future neurobiological or clinical research. Techniques to be used: M/EEG fMRI ultra-high field (7T) fMRI simultaneous EEG/fMRI tES